Department of Public Health, Graduate School, Konyang University, Daejeon 35365, Korea.
Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon 35365, Korea.
Int J Environ Res Public Health. 2021 Nov 16;18(22):12035. doi: 10.3390/ijerph182212035.
Vaccination against COVID-19 is an important strategy for its control. Assessing the willingness to accept the COVID-19 vaccine in different subgroups is important for an inclusive vaccination program design. Our aim was to determine the COVID-19 vaccine acceptance rate and associated factors among foreigners in South Korea. An online cross-sectional study was carried out from May to June 2021. In this study, 710 individuals participated and most were aged between 26 and 29 (36.1%) years. Overall, 70.8% were willing to receive the vaccine. Males were less likely to accept the vaccine than females (OR: 0.5; 95% CI: 0.4-0.7, < 0.001). Single people were more likely to receive the vaccine than those who were married (OR: 1.4; 95% CI: 0.9-2.0, = 0.04). Other factors associated with willingness to accept COVID-19 vaccine were; vaccine convenience (OR: 1.7; 95% CI: 1.2-2.3, = 0.002), doctors' recommendation (OR: 2.8; 95% CI: 2.0-3.9, < 0.001), vaccine price (OR: 1.7; 95% CI: 1.2-2.3, = 0.003), vaccine effectiveness (OR: 8.3; 95% CI: 5.8-12.1, < 0.001), vaccine importance (OR: 7.9; 95% CI: 4.6-14.1, < 0.001), and vaccine safety (OR: 6.9; 95% CI: 4.5-10.8, < 0.001). Providing more information on vaccine safety and effectiveness is required to increase vaccine acceptance.
接种 COVID-19 疫苗是控制该疾病的一项重要策略。评估不同亚组人群对接种 COVID-19 疫苗的意愿,对于制定包容性疫苗接种计划至关重要。本研究旨在确定韩国外国人对 COVID-19 疫苗的接种率及相关因素。这是一项 2021 年 5 月至 6 月进行的在线横断面研究。该研究共纳入 710 名参与者,年龄主要集中在 26 至 29 岁(36.1%)。总体而言,70.8%的参与者愿意接种疫苗。与女性相比,男性接种疫苗的意愿较低(OR:0.5;95%CI:0.4-0.7, < 0.001)。单身人群比已婚人群更愿意接种疫苗(OR:1.4;95%CI:0.9-2.0, = 0.04)。与愿意接种 COVID-19 疫苗相关的其他因素包括:疫苗便利性(OR:1.7;95%CI:1.2-2.3, = 0.002)、医生推荐(OR:2.8;95%CI:2.0-3.9, < 0.001)、疫苗价格(OR:1.7;95%CI:1.2-2.3, = 0.003)、疫苗有效性(OR:8.3;95%CI:5.8-12.1, < 0.001)、疫苗重要性(OR:7.9;95%CI:4.6-14.1, < 0.001)和疫苗安全性(OR:6.9;95%CI:4.5-10.8, < 0.001)。为了提高疫苗接种率,需要提供更多关于疫苗安全性和有效性的信息。